syngo.via for oncology
When diagnosing a patient, you want to know:
- Is there a tumor?
- Are there metastases and where?
- What are the respective lesion characteristics?
Once a lesion has been detected, precise staging is key to fighting cancer effectively. You need to investigate the tumor for size and other signs of malignancy and determine whether and where the tumor has metastasized. syngo®.via comes with a variety of tools and features to support you during lesion detection and evaluation.
Automated case preparation
With syngo.via, reading physicians can immediately focus on the essentials: images and diagnosing. When opening a patient’s file, images are already complete, prepared, and ready to be read. syngo.via loads oncology cases to the appropriate application, pre-processes the images according to disease-specific requirements, sorts them into a synchronized dedicated layout, and gathers previous image data from archives. For example, for each MR whole body study, syngo.via automatically structures and sorts all images from head to toe, from soft tissue to bone contrast. Follow-up studies and all prior studies are loaded and displayed in a “compare layout.”
In short, you leave the preparation to syngo.via in order to reduce time spent preparing data and concentrate more on reading and increasing throughput.
Structured case navigation
syngo.via helps make oncology reading fast, intuitive, and less error prone. It enhances handling of large amounts of data and provides a high degree of automation and advanced ergonomics to help physicians focus on the essentials.
The automatic anatomic registration facilitates synchronized scrolling, zooming and rotating, and new tools like 3D Reference Point allow fast localization of the same point in all series and planes. With syngo.via, the reading physician can just follow the suggested pre-defined workflow steps throughout the complete dataset and read the case faster and easier, even when comparing follow-up exams with previous ones. What’s more, suggested workflows are specific to the type of modality and to the case at hand and you can customize the complete workflow to suit your needs.
See the whole picture: Drag and drop to combine additional image data
syngo.via is a true multi-modality platform that provides all tools necessary to read and to share images from PET, CT, MR, CR/DR digital X-ray, fluoroscopy, angiography, and ultrasound. syngo.via also allows combinations of images from multiple modalities whenever needed – to give you additional and potentially decisive information for your oncology cases. Should any additional image data from other modalities or previous scans be available for your patient, you can easily drag and drop them into your oncology reading layout. These images will be registered automatically with the data sets already in use and displayed on up to two monitors. For example, you could easily create side-by-side displays of MR and ultrasound images for prostate cases, or use automatic image fusion for CT, MR, and PET images to read brain and other cases. In sum, this gives you the edge in diagnostic information for oncology reading.
Images – the way you want them
syngo.via offers the 2D and 3D capabilities you want. Flexible screen layouts and dual-monitor support allow you to switch instantly between 2D- and 3D-reading strategies so you can combine with ease the advantages of both. For example, switch to 3D views of any contrast with just one click in MR Reading – without changing the software or task card – or switch instantly between the 3D endoscopic view and the corresponding 2D images within syngo.CT Colonography.
Seamless integration of second reader tools to enhance diagnostic confidence
Using syngo.via’s computer-aided detection (CAD) tools as a second reader can help improve diagnostic confidence while maintaining a fast and efficient workflow. The second reader tools include syngo.CT Lung CAD for the detection of solid pulmonary nodules in diagnostic chest CT exams and syngo.CT Colonography – PEV (Polyp Enhanced Viewing)2 for use in CT colonography exams.
In addition to these second reader tools, syngo.via facilitates live collaboration between two syngo.via clients through desktop sharing. This allows you to easily ask a colleague for a second opinion, without needing to leave the case.
Lesion segmentation – you mark the lesion, syngo.via the boundaries
syngo.via provides dedicated automated and accurate segmentation and quantification functionalities. All you need to do is to select the lesion and syngo.via generates a boundary around the lesion and computes its volume – there is no need to spend time on manual 3D segmentations. syngo.via with the syngo.mCT Oncology1 Engine Pro provides a unique integration of PET and CT segmentation tools: SUV-based 3D iso-contouring is available in the same application with automated CT lung, liver, and lymph segmentation tools. This facilitates accurate staging and total tumor burden assessment.
Measurements for daily work and for research – automated and reproducible
With syngo.via, you can measure a distance, a region of interest (ROI), or mark a suspicious lesion with a single click. For further evaluation of the lesion within the images, syngo.via offers a variety of automated and thus reproducible measurements adequate for daily work and for research purposes, such as RECIST 1.0 and RECIST 1.1 calculation, WHO calculation, mean HU, multiple SUV calculation methods, doubling time, shape parameters, and histogram. Besides calcualtion of diameters, syngo.via with the syngo.mCT Oncology1 Engine, with the syngo.CT Oncology Engine, or with the syngo.MR Onco Engine are also capable of automated volume measurement of a lesion by calculating the space enclosed within the segmented tumor, leading to high reproducibility of measurements and thus helping to reduce inter-reader or intra-reader variability.
1Regulatory clearance with syngo.PET&CT Oncology.
2syngo.via can be used as a stand-alone device or together with a variety of syngo.via-based software options which are medical devices on their own rights.